Borderline-tuberculoid relapse in lepromatous leprosy.
We report details of 2 patients who had been treated for a long time by dapsone monotherapy and who had remained smear negative for over 10 years, but were found to have relapsed with borderline-tuberculoid (BT) leprosy.
Girdhar
B K
BK
Central JALMA Institute for Leprosy, Tajganj, AGRA, New Delhi.
Girdhar
A
A
Chauhan
S L
SL
Malaviya
G N
GN
Husain
S
S
Mukherjee
A
A
D003622:Dapsone / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015439:Leprosy, Borderline / Q000473:pathology; D015440:Leprosy, Lepromatous / Q000188:drug therapy* / Q000473:pathology; D015441:Leprosy, Tuberculoid / Q000473:pathology; D008297:Male; D008875:Middle Aged; D012008:Recurrence
D003622:Dapsone